drug candidate
The Latest
-
Emergent Bio, US Gov't Enter Into $628 Million COVID-19 Drug Deal
The deal also includes an $85.5 million investment to boost Emergent's non-viral vaccine manufacturing capability. The deal also includes an $85.5 million investment to boost Emergent's non-viral vaccine manufacturing capability.